Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1996
12/04/1996EP0745068A1 Heteroaryl-substituted deoxy glycero-phosphoethanolamines
12/04/1996EP0745063A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
12/04/1996EP0744957A1 Composition and method for preventing and treating inflammation with immunoglobulin a
12/04/1996EP0744955A1 Cyclic heptapeptide anti-inflammatory agent
12/04/1996CN1137275A O-aryl O-alkyl O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
12/04/1996CN1137274A 6-oxo-nucleosides useful as immunosuppressants
12/04/1996CN1137268A Amidino derivatives useful as nitric oxide synthase inhibitors
12/04/1996CN1137237A Method of treating androgenic alopecia with 5-alpha reductase inhibitors
12/03/1996US5580989 Antiallergens, antiinflammatory agents
12/03/1996US5580985 Substituted pyrazoles for the treatment of inflammation
12/03/1996US5580888 Administering for therapy and prophylaxis of asthma; potent phosphodiesterase iv isoenzyme inhibitors
12/03/1996US5580865 2,2-disubstituted cephem sulphones
12/03/1996US5580755 Human pluripotent granulocyte colony-stimulating factor
11/1996
11/28/1996WO1996037626A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037488A1 Piperazine derivatives
11/28/1996WO1996037239A1 Peptide radiopharmaceutical applications
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2219492A1 Peptide radiopharmaceutical applications
11/27/1996EP0743953A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
11/27/1996EP0743951A1 Substituted lactose derivatives as cell adhesion inhibitors
11/27/1996EP0743945A1 Heterocyclic compounds and their preparation and use
11/27/1996EP0743944A1 Azacyclic derivatives
11/27/1996EP0743940A1 New compounds with analgesic and local anaesthetic effect
11/27/1996EP0743939A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
11/27/1996EP0743938A1 Substituted spiro compounds for the treatment of inflammation
11/27/1996EP0489839B1 Novel hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
11/27/1996CN1136808A Pseudodipeptide product having imidazole grouping and applications
11/27/1996CN1136567A Dioxide pyrrolo-pyrrolo derivatives
11/27/1996CN1033365C Preparing method for lipides composition containing scutellaria compound
11/26/1996US5578634 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors
11/26/1996US5578631 Methods of combating Pneumocystis carinii pneumonia and compounds useful therefor
11/26/1996US5578617 Method and compositions for treating age related disorders
11/26/1996US5578616 Antiinflammatory agents, antiallergens, treatment for gastrointestinal and cardiovascular disorders
11/26/1996US5578612 Indole derivatives
11/26/1996US5578576 Nutrient solution for reducing side effects of nonsteroidal antiinflammatory drugs
11/26/1996CA2113916C 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent
11/26/1996CA2078287C Nitroxides as protectors against oxidative stress
11/21/1996WO1996036713A2 Eck receptor ligands
11/21/1996WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996WO1996036626A1 Cyclohexyl dihydrobenzofuranes
11/21/1996WO1996036625A1 Phenyl dihydrobenzofuranes
11/21/1996WO1996036623A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996WO1996036620A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996WO1996036617A1 Substituted oxazoles for the treatment of inflammation
11/21/1996WO1996036608A1 α,β-UNSATURATED KETONE DERIVATIVES
11/21/1996WO1996036350A1 Use of il-13 to induce 15-lipoxygenase
11/21/1996WO1996036343A1 Use of deproteinised haemodialysate
11/21/1996WO1996036324A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
11/21/1996WO1996030042A3 Methods of treating inflammation and compositions therefor
11/21/1996WO1996029407A3 Cellubrevin homologs
11/21/1996DE19518156A1 Verwendung von deproteinisiertem Hämodialysat Use of deproteinized haemodialysate
11/21/1996CA2221692A1 Substituted oxazoles for the treatment of inflammation
11/21/1996CA2221449A1 Use of il-13 to induce 15-lipoxygenase
11/21/1996CA2221380A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996CA2221357A1 Phenyl dihydrobenzofuranes
11/21/1996CA2221351A1 Cyclohexyl dihydrobenzofuranes
11/21/1996CA2220687A1 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
11/21/1996CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996CA2219129A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/20/1996EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
11/20/1996EP0742717A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/20/1996CN1136318A 16-substituted -4-aza-androstane 5-alpha-reductase isoazyne 1 inhibitors
11/20/1996CN1136316A Biologically active silicon compounds and their therapeutic and cosmetic applications
11/20/1996CN1136315A Method for preparing concentrated biologically active silicon compounds
11/20/1996CN1136314A Isoxazoline compounds as antiinflammatory agents
11/20/1996CN1136312A Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136311A Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1033325C Preparation of antiinflammatory hydroxamic acids and N-hydroxyureas
11/19/1996US5576444 Cyclic imino derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
11/19/1996US5576438 Lipoxygenase inhibitors; antiallergens, antiinflammatory agents
11/19/1996US5576435 Process and intermediates for the preparation of excitatory amino acid receptor antagonists
11/19/1996US5576330 Mixture of an angiogenesis inhibitor and an antitumor agent
11/19/1996US5576325 Pyrrolyl-4h-pyranoquinolines
11/19/1996US5576024 Buffered matrix aspirin
11/19/1996US5575993 Useful as herbicides, microbiocides, plant growth regulators, pharmaceuticals, disinfectants, algicides, sanitizers, and preservatives
11/19/1996CA2111460C Tetrahydrobenzazepine derivatives which inhibit lipoxygenase
11/19/1996CA2109613C Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
11/19/1996CA2106200C Stereoselective preparation of substituted piperidines
11/19/1996CA1338728C Cyclosporins and their use a pharmaceuticals
11/14/1996WO1996035782A1 Il-6 activity inhibitor
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035714A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996WO1996035712A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996WO1996035711A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996WO1996035700A1 Saccharopeptides and derivatives thereof
11/14/1996WO1996035687A1 Peptidyl compounds and their therapeutic use
11/14/1996WO1996035467A1 Coarse spray delivery of functional biologic materials
11/14/1996WO1996035429A1 Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations
11/14/1996WO1996035419A1 Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis
11/14/1996DE19518221A1 Verwendung nichtsteroidaler Entzündungshemmer zur Verbesserung der physiologischen Verträglichkeit partikulärer pharmazeutischer Zubereitungen Use of non-steroidal anti-inflammatory drugs to improve the physiological tolerance particulate pharmaceutical preparations
11/14/1996CA2220508A1 Saccharopeptides and derivatives thereof
11/14/1996CA2220052A1 Use of nonsteroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations
11/14/1996CA2219973A1 Peptidyl compounds and their therapeutic use
11/14/1996CA2218879A1 Coarse spray delivery of functional biologic materials
11/14/1996CA2217859A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996CA2217857A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996CA2217850A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
1 ... 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 ... 1272